SMO and acute myeloid leukemia: Constitutional activation can also be effected by mutations to other elements of the signaling pathway, such as gain of function mutations in SMO that counteract inhibition by PTCH demonstrated in sporadic BCCs (36), loss of the GLI3 suppressor via methylation in AML (39) and inactivation of SUFU in medulloblastoma (40).